Jon Bates - Mar 12, 2024 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Role
Chief Financial Officer
Signature
Jon Bates
Stock symbol
NUTX
Transactions as of
Mar 12, 2024
Transactions value $
$0
Form type
4
Date filed
3/14/2024, 04:44 PM
Previous filing
Jun 20, 2023
Next filing
Jun 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUTX Common Stock Options Exercise +49.5K +55.31% 139K Mar 12, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUTX Restricted Stock Units Options Exercise $0 -49.5K -50% $0.00 49.5K Mar 12, 2024 Common Stock 49.5K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the settlement of restricted stock units (RSUs) that vested on March 1, 2024 through the issuance of shares of Common Stock.
F2 Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
F3 Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated April 1, 2023, the 148,515 RSUs granted to Mr. Bates will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025